Your browser doesn't support javascript.
loading
A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.
Heiligenstein, J H; Tollefson, G D; Faries, D E.
Affiliation
  • Heiligenstein JH; Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285.
Int Clin Psychopharmacol ; 8(4): 247-51, 1993.
Article in En | MEDLINE | ID: mdl-8277143
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Fluoxetine / Depressive Disorder Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 1993 Document type: Article Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Fluoxetine / Depressive Disorder Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 1993 Document type: Article Country of publication: Reino Unido